COVID-19 R&D – Vaccine Manufacturing/Scaling

Milestones :: Perspectives :: Research

 

COVID-19 R&D – Vaccine Manufacturing/Scaling

Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
:: First participants dosed at NYU Grossman School of Medicine and University of Maryland School of Medicine
:: Pfizer and BioNTech ramping up manufacturing capabilities to further increase production capacity in 2020/2021
May 05, 2020

Milken Institute COVID-19 Tracker Update Identifies More Than 100 Vaccines and Nearly 200 Treatments in Development
Nine vaccines and more than 50 treatment candidates reach clinical trials.
May 04, 2020
The Milken Institute COVID-19 Treatment and Vaccine Tracker has identified more than 111 vaccines and 197 treatments in the pipeline to treat and prevent COVID-19. This is an increase from the 55 treatments and 38 vaccine candidates identified when the Institute first started tracking treatments and vaccines in early March…